Pentagastrin
- Generic Name
- Pentagastrin
- Drug Type
- Small Molecule
- Chemical Formula
- C37H49N7O9S
- CAS Number
- 5534-95-2
- Unique Ingredient Identifier
- EF0NX91490
- Background
A synthetic pentapeptide that mimics the actions of endogenous gastrin when given parenterally. It works by stimulating the secretion of gastric acid, pepsin, and intrinsic factor. It has also been used as a diagnostic aid.
- Indication
Used as a diagnostic aid for evaluation of gastric acid secretory function
- Associated Conditions
- Achlorhydria, Gastric Acid Suppression, Gastric hypersecretion, Zollinger-Ellison Syndrome
A New Method for Determining Gastric Acid Output Using a Wireless Capsule
Completed
- Conditions
- Gastric Acid Secretory Disorders
- Interventions
- Device: Pentagastrin Injection BP
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2025-04-22
- Target Recruit Count
- 80
- Registration Number
- NCT00702533
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath